Literature DB >> 28490655

Practice guideline summary: Reducing brain injury following cardiopulmonary resuscitation: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.

Romergryko G Geocadin1, Eelco Wijdicks1, Melissa J Armstrong1, Maxwell Damian1, Stephan A Mayer1, Joseph P Ornato1, Alejandro Rabinstein1, José I Suarez1, Michel T Torbey1, Richard M Dubinsky1, Jason Lazarou1.   

Abstract

OBJECTIVE: To assess the evidence and make evidence-based recommendations for acute interventions to reduce brain injury in adult patients who are comatose after successful cardiopulmonary resuscitation.
METHODS: Published literature from 1966 to August 29, 2016, was reviewed with evidence-based classification of relevant articles. RESULTS AND RECOMMENDATIONS: For patients who are comatose in whom the initial cardiac rhythm is either pulseless ventricular tachycardia (VT) or ventricular fibrillation (VF) after out-of-hospital cardiac arrest (OHCA), therapeutic hypothermia (TH; 32-34°C for 24 hours) is highly likely to be effective in improving functional neurologic outcome and survival compared with non-TH and should be offered (Level A). For patients who are comatose in whom the initial cardiac rhythm is either VT/VF or asystole/pulseless electrical activity (PEA) after OHCA, targeted temperature management (36°C for 24 hours, followed by 8 hours of rewarming to 37°C, and temperature maintenance below 37.5°C until 72 hours) is likely as effective as TH and is an acceptable alternative (Level B). For patients who are comatose with an initial rhythm of PEA/asystole, TH possibly improves survival and functional neurologic outcome at discharge vs standard care and may be offered (Level C). Prehospital cooling as an adjunct to TH is highly likely to be ineffective in further improving neurologic outcome and survival and should not be offered (Level A). Other pharmacologic and nonpharmacologic strategies (applied with or without concomitant TH) are also reviewed.
© 2017 American Academy of Neurology.

Entities:  

Mesh:

Year:  2017        PMID: 28490655      PMCID: PMC5447399          DOI: 10.1212/WNL.0000000000003966

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  38 in total

1.  Post-cardiac arrest syndrome: epidemiology, pathophysiology, treatment, and prognostication. A consensus statement from the International Liaison Committee on Resuscitation (American Heart Association, Australian and New Zealand Council on Resuscitation, European Resuscitation Council, Heart and Stroke Foundation of Canada, InterAmerican Heart Foundation, Resuscitation Council of Asia, and the Resuscitation Council of Southern Africa); the American Heart Association Emergency Cardiovascular Care Committee; the Council on Cardiovascular Surgery and Anesthesia; the Council on Cardiopulmonary, Perioperative, and Critical Care; the Council on Clinical Cardiology; and the Stroke Council.

Authors:  Robert W Neumar; Jerry P Nolan; Christophe Adrie; Mayuki Aibiki; Robert A Berg; Bernd W Böttiger; Clifton Callaway; Robert S B Clark; Romergryko G Geocadin; Edward C Jauch; Karl B Kern; Ivan Laurent; W T Longstreth; Raina M Merchant; Peter Morley; Laurie J Morrison; Vinay Nadkarni; Mary Ann Peberdy; Emanuel P Rivers; Antonio Rodriguez-Nunez; Frank W Sellke; Christian Spaulding; Kjetil Sunde; Terry Vanden Hoek
Journal:  Circulation       Date:  2008-10-23       Impact factor: 29.690

2.  Intra-arrest transnasal evaporative cooling: a randomized, prehospital, multicenter study (PRINCE: Pre-ROSC IntraNasal Cooling Effectiveness).

Authors:  Maaret Castrén; Per Nordberg; Leif Svensson; Fabio Taccone; Jean-Louise Vincent; Didier Desruelles; Frank Eichwede; Pierre Mols; Tilmann Schwab; Michel Vergnion; Christian Storm; Antonio Pesenti; Jan Pachl; Fabien Guérisse; Thomas Elste; Markus Roessler; Harald Fritz; Pieterjan Durnez; Hans-Jörg Busch; Becky Inderbitzen; Denise Barbut
Journal:  Circulation       Date:  2010-08-02       Impact factor: 29.690

3.  Nimodipine after resuscitation from out-of-hospital ventricular fibrillation. A placebo-controlled, double-blind, randomized trial.

Authors:  R O Roine; M Kaste; A Kinnunen; P Nikki; S Sarna; S Kajaste
Journal:  JAMA       Date:  1990-12-26       Impact factor: 56.272

4.  Effect of Inhaled Xenon on Cerebral White Matter Damage in Comatose Survivors of Out-of-Hospital Cardiac Arrest: A Randomized Clinical Trial.

Authors:  Ruut Laitio; Marja Hynninen; Olli Arola; Sami Virtanen; Riitta Parkkola; Jani Saunavaara; Risto O Roine; Juha Grönlund; Emmi Ylikoski; Johanna Wennervirta; Minna Bäcklund; Päivi Silvasti; Eija Nukarinen; Marjaana Tiainen; Antti Saraste; Mikko Pietilä; Juhani Airaksinen; Leena Valanne; Juha Martola; Heli Silvennoinen; Harry Scheinin; Veli-Pekka Harjola; Jussi Niiranen; Kirsi Korpi; Marjut Varpula; Outi Inkinen; Klaus T Olkkola; Mervyn Maze; Tero Vahlberg; Timo Laitio
Journal:  JAMA       Date:  2016-03-15       Impact factor: 56.272

5.  Prehospital therapeutic hypothermia for comatose survivors of cardiac arrest: a randomized controlled trial.

Authors:  A Kämäräinen; I Virkkunen; J Tenhunen; A Yli-Hankala; T Silfvast
Journal:  Acta Anaesthesiol Scand       Date:  2009-06-03       Impact factor: 2.105

6.  Early high-dose erythropoietin therapy and hypothermia after out-of-hospital cardiac arrest: a matched control study.

Authors:  Alain Cariou; Yann-Erick Claessens; Frederic Pène; Jean-Sebastien Marx; Christian Spaulding; Cyrla Hababou; Nicole Casadevall; Jean-Paul Mira; Pierre Carli; Olivier Hermine
Journal:  Resuscitation       Date:  2007-11-26       Impact factor: 5.262

7.  Does early administration of selenium improve neurological outcome after cardiac arrest?

Authors:  Johann Reisinger; Kurt Höllinger; Wolfgang Lang; Christoph Steiner; Thomas Winter; Andreas Winter; Michael Mori; Alexander Lindorfer; Daniel Kiblböck; Peter Siostrzonek
Journal:  Am J Emerg Med       Date:  2009-02       Impact factor: 2.469

8.  Delay in cooling negates the beneficial effect of mild resuscitative cerebral hypothermia after cardiac arrest in dogs: a prospective, randomized study.

Authors:  K Kuboyama; P Safar; A Radovsky; S A Tisherman; S W Stezoski; H Alexander
Journal:  Crit Care Med       Date:  1993-09       Impact factor: 7.598

9.  Hypothermia in comatose survivors from out-of-hospital cardiac arrest: pilot trial comparing 2 levels of target temperature.

Authors:  Esteban Lopez-de-Sa; Juan R Rey; Eduardo Armada; Pablo Salinas; Ana Viana-Tejedor; Sandra Espinosa-Garcia; Mercedes Martinez-Moreno; Ervigio Corral; Jose Lopez-Sendon
Journal:  Circulation       Date:  2012-11-06       Impact factor: 29.690

10.  Effect of prehospital induction of mild hypothermia on survival and neurological status among adults with cardiac arrest: a randomized clinical trial.

Authors:  Francis Kim; Graham Nichol; Charles Maynard; Al Hallstrom; Peter J Kudenchuk; Thomas Rea; Michael K Copass; David Carlbom; Steven Deem; W T Longstreth; Michele Olsufka; Leonard A Cobb
Journal:  JAMA       Date:  2014-01-01       Impact factor: 56.272

View more
  18 in total

1.  Infants Uniquely Express High Levels of RBM3 and Other Cold-Adaptive Neuroprotectant Proteins in the Human Brain.

Authors:  Travis C Jackson; Shawn E Kotermanski; Patrick M Kochanek
Journal:  Dev Neurosci       Date:  2018-11-06       Impact factor: 2.984

2.  Approach to assessing and using clinical practice guidelines.

Authors:  Melissa J Armstrong; Gary S Gronseth
Journal:  Neurol Clin Pract       Date:  2018-02

Review 3.  The Implementation of Targeted Temperature Management: An Evidence-Based Guideline from the Neurocritical Care Society.

Authors:  Lori Kennedy Madden; Michelle Hill; Teresa L May; Theresa Human; Mary McKenna Guanci; Judith Jacobi; Melissa V Moreda; Neeraj Badjatia
Journal:  Neurocrit Care       Date:  2017-12       Impact factor: 3.210

4.  Independent Functional Outcomes after Prolonged Coma following Cardiac Arrest: A Mechanistic Hypothesis.

Authors:  Peter B Forgacs; Orrin Devinsky; Nicholas D Schiff
Journal:  Ann Neurol       Date:  2020-02-11       Impact factor: 10.422

Review 5.  The post-cardiac arrest syndrome: A case for lung-brain coupling and opportunities for neuroprotection.

Authors:  Nguyen Mai; Kathleen Miller-Rhodes; Sara Knowlden; Marc W Halterman
Journal:  J Cereb Blood Flow Metab       Date:  2019-03-13       Impact factor: 6.200

6.  Evidence Summary of Temperature Management for Comatose Patients after Cardiopulmonary Resuscitation in ICUs.

Authors:  Zhuo Yang; Ting Ni; Yan Yang; Hui Zhang; Hongli Chi
Journal:  Appl Bionics Biomech       Date:  2022-06-30       Impact factor: 1.664

7.  Severe cerebral edema in substance-related cardiac arrest patients.

Authors:  Annelise M Kulpanowski; William A Copen; Brandon L Hancock; Eric S Rosenthal; David A Schoenfeld; Jacob A Dodelson; Brian L Edlow; W Taylor Kimberly; Edilberto Amorim; M Brandon Westover; Ming Ming Ning; Pamela W Schaefer; Rajeev Malhotra; Joseph T Giacino; David M Greer; Ona Wu
Journal:  Resuscitation       Date:  2022-02-08       Impact factor: 6.251

8.  Effect of Body Temperature on Cerebral Autoregulation in Acutely Comatose Neurocritically Ill Patients.

Authors:  Krishma Adatia; Romergryko G Geocadin; Ryan Healy; Wendy Ziai; Luciano Ponce-Mejia; Mirinda Anderson-White; Dhaval Shah; Batya R Radzik; Caitlin Palmisano; Charles W Hogue; Charles Brown; Lucia Rivera-Lara
Journal:  Crit Care Med       Date:  2018-08       Impact factor: 7.598

9.  Association Between Target Temperature Variability and Neurologic Outcomes for Patients Receiving Targeted Temperature Management at 36°C After Cardiac Arrest: A Retrospective Cohort Study.

Authors:  Makayla Cordoza; Hilaire Thompson; Elizabeth Bridges; Robert Burr; David Carlbom
Journal:  Ther Hypothermia Temp Manag       Date:  2020-06-16       Impact factor: 1.369

10.  Energy Expenditure and Shivering Severity During Targeted Temperature Management at 36°C After Cardiac Arrest: A Case Series.

Authors:  Makayla Cordoza; Lingtak-Neander Chan; Elizabeth Bridges; David J Carlbom; Hilaire Thompson
Journal:  Crit Care Nurs Q       Date:  2020 Jul/Sep
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.